A Phase I Study of SHR1459 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions

Health, Subjective

Interventions

DRUG

SHR1459/Itraconazole

SHR1459 will be administered on Day 1 and Day 7. Itraconazole will be administered on Day 4 to Day 8

Trial Locations (1)

Shanghai General Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04455100 - A Phase I Study of SHR1459 in Healthy Subjects | Biotech Hunter | Biotech Hunter